## Protocol Section
### Identification Module
**NCT ID:** NCT06295679

**Brief Title:** A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease

**Official Title:** A Real-world, Prospective, Observational Study Assessing the Effectiveness of Repatha® Used in Combination With Standard of Care Compared With Standard of Care Alone on Major Cardiovascular Events in Chinese Patients With Established Atherosclerotic Cardiovascular Disease

#### Organization Study ID Info
**ID:** 20180442
#### Organization
**Class:** INDUSTRY
**Full Name:** Amgen
### Status Module
#### Completion Date
**Date:** 2028-12-19

**Type:** ESTIMATED

#### Expanded Access Info
#### Last Update Post Date
**Date:** 2024-05-16

**Type:** ACTUAL

**Last Update Submit Date:** 2024-05-15

**Overall Status:** RECRUITING

#### Primary Completion Date
**Date:** 2028-12-19

**Type:** ESTIMATED

#### Start Date
**Date:** 2022-12-19

**Type:** ACTUAL

**Status Verified Date:** 2024-05

#### Study First Post Date
**Date:** 2024-03-06
**Type:** ACTUAL
**Study First Submit Date:** 2024-02-26
**Study First Submit QC Date:** 2024-03-04
### Sponsor Collaborators Module

#### Lead Sponsor

**Class:** INDUSTRY

**Name:** Amgen

#### Responsible Party

**Type:** SPONSOR

### Oversight Module

**Is FDA Regulated Device:** False

**Is FDA Regulated Drug:** False

**Oversight Has DMC:** False

### Description Module

**Brief Summary:** The primary objective of the study is to evaluate real-world effectiveness of treatment with Repatha® in combination with SOC, compared with SOC alone, on the risk for cardiovascular (CV) death, myocardial infarction (MI), stroke, hospitalization for unstable angina, or coronary revascularization, whichever occurs first, in participants with established atherosclerotic CV disease (ASCVD) treated with SOC, according to local clinical practice.

### Conditions Module

**Conditions:**

- Major Cardiovascular Event

- Established Atherosclerotic Cardiovascular Disease

**Keywords:**

- Cardiovascular death

- Myocardial infarction

- Stroke

- Unstable angina

- Coronary revascularization

- Atherosclerotic Cardiovascular Disease

- Repatha

### Design Module

#### Design Info

**Observational Model:** COHORT

**Time Perspective:** PROSPECTIVE

#### Enrollment Info

**Count:** 7000

**Type:** ESTIMATED

**Study Type:** OBSERVATIONAL

### Arms Interventions Module

#### Arm Group 1

**Description:** Participants with clinically evident ASCVD treated with Repatha® in combination with SOC in a clinical setting. To ensure that the recruitment strategy has as little impact on routine practice as possible, the decision to treat the participant with Repatha® with SOC will be made independently of, and before, enrollment in the study.

**Label:** Repatha® with Standard of Care Exposure

#### Arm Group 2

**Description:** Participants with clinically evident ASCVD treated with SOC alone in a clinical setting. To ensure that the recruitment strategy has as little impact on routine practice as possible, the decision to treat the participant with SOC only will be made independently of, and before, enrollment in the study.

**Label:** Standard of Care Exposure

### Outcomes Module

#### Primary Outcomes

**Measure:** Time to CV Death, MI, Hospitalization for Unstable Angina, Stroke, or Coronary Revascularization, Whichever Occurs First

**Time Frame:** Up to 72 months

#### Secondary Outcomes

**Measure:** Time to CV Death, MI, or Stroke, Whichever Occurs First

**Time Frame:** Up to 72 months

**Measure:** Change in Low-density Lipoprotein Cholesterol (LDL-C) From Baseline

**Time Frame:** Baseline and end of follow-up (up to 72 months)

**Measure:** Percent Change in LDL-C From Baseline

**Time Frame:** Baseline and end of follow-up (up to 72 months)

**Measure:** Number of Participants Who Experienced Adverse Events

**Time Frame:** Up to 72 months

**Measure:** Number of Participants Who Experienced Adverse Drug Reactions

**Time Frame:** Up to 72 months

### Eligibility Module

**Eligibility Criteria:** Inclusion Criteria:

* Adult participants ≥ 18 years of age.
* Participants or participant's legally authorized representative has provided informed consent to participate in this study.
* Participants who meet one of the following:
* Prescribed Repatha® in addition to an existing SOC treatment according to local guidelines and approved label.

OR

* Already received SOC treatment prior to enrollment.
* Participants with ANY of the following.
* Diagnosis of MI OR stroke within 2 years before enrollment.
* 2 MIs OR ≥ 2 strokes OR (≥ 1 MI AND ≥ 1 stroke) any time before enrollment.
* Diagnosis of (MI OR stroke) AND diabetes.
* Diagnosis of (MI OR stroke) AND documented multivessel disease (defined as \> 50% stenosis of ≥ 2 major coronary arteries on coronary angiography or coronary artery contrast enhanced computed tomography).
* Diagnosis of symptomatic peripheral arterial disease.
* Most recent fasting LDL-C ≥ 70 mg/dL (≥ 1.8 mmol/L) or nonhigh-density lipoprotein cholesterol (non-HDL-C) ≥ 100 mg/dL (≥ 2.6 mmol/L) within 6 months prior to enrollment.
* Most recent fasting triglycerides ≤ 400 mg/dL (≤ 4.5 mmol/L) within 6 months prior to enrollment.

Exclusion Criteria:

* Stroke within past 1 month.
* Known hemorrhagic stroke at any time.
* Stroke due to thromboembolic event.
* Any prior use of Repatha® or other proprotein convertase subtilisin/kexin type 9 inhibition treatments within past 6 months prior to enrollment.
* Participants currently enrolled in another study involving any investigational procedure, device or drug.
* Participants prescribed Repatha® with a history of severe hypersensitivity or allergy to any subsidiary.

**Maximum Age:** 150 Years

**Minimum Age:** 18 Years

**Sampling Method:** NON_PROBABILITY_SAMPLE

**Sex:** ALL

**Standard Ages:**

- ADULT

- OLDER_ADULT

**Study Population:** The study population comprises Chinese participants with established ASCVD treated with Repatha® in combination with SOC or with SOC alone in a clinical setting which includes any primary through tertiary healthcare setting where Repatha® is prescribed.

### Contacts Locations Module

#### Central Contacts

**Contact 1:**

**Email:** medinfo@amgen.com

**Name:** Amgen Call Center

**Phone:** 866-572-6436

**Role:** CONTACT

#### Locations

**Location 1:**

**City:** Beijing

**Country:** China

**Facility:** China Japan Friendship Hospital

**State:** Beijing

**Status:** RECRUITING

**Zip:** 100029

**Location 2:**

**City:** Beijing

**Country:** China

**Facility:** Peking University First Hospital

**State:** Beijing

**Status:** RECRUITING

**Zip:** 100034

**Location 3:**

**City:** Beijing

**Country:** China

**Facility:** Beijing Haidian Hospital

**State:** Beijing

**Status:** RECRUITING

**Zip:** 100086

**Location 4:**

**City:** Beijing

**Country:** China

**Facility:** Peking University Third Hospital

**State:** Beijing

**Status:** RECRUITING

**Zip:** 100191

**Location 5:**

**City:** Beijing

**Country:** China

**Facility:** Beijing Hospital

**State:** Beijing

**Status:** RECRUITING

**Zip:** 100730

**Location 6:**

**City:** Chongqing

**Country:** China

**Facility:** Chongqing Emergency Medical Center

**State:** Chongqing

**Status:** RECRUITING

**Zip:** 400014

**Location 7:**

**City:** Chongqing

**Country:** China

**Facility:** Chongqing General Hospital

**State:** Chongqing

**Status:** RECRUITING

**Zip:** 401121

**Location 8:**

**City:** Dong Guan

**Country:** China

**Facility:** Dongguan Songshan Lake Central Hospital

**State:** Guangdong

**Status:** RECRUITING

**Zip:** 523127

**Location 9:**

**City:** Foshan

**Country:** China

**Facility:** The First Peoples Hospital of Foshan

**State:** Guangdong

**Status:** RECRUITING

**Zip:** 528000

**Location 10:**

**City:** Guangzhou

**Country:** China

**Facility:** The First Affiliated Hospital of Shantou University Medical College

**State:** Guangdong

**Status:** RECRUITING

**Zip:** 510280

**Location 11:**

**City:** Guangzhou

**Country:** China

**Facility:** Zhujiang Hospital of Southern Medical University

**State:** Guangdong

**Status:** RECRUITING

**Zip:** 510280

**Location 12:**

**City:** Guangzhou

**Country:** China

**Facility:** Nanfang Hospital, Southern Medical University

**State:** Guangdong

**Status:** RECRUITING

**Zip:** 510515

**Location 13:**

**City:** Guangzhou

**Country:** China

**Facility:** The First Affiliated Hospital of Jinan University

**State:** Guangdong

**Status:** RECRUITING

**Zip:** 510630

**Location 14:**

**City:** Guangzhou

**Country:** China

**Facility:** The Third Affiliated Hospital of Sun Yat-sen University

**State:** Guangdong

**Status:** RECRUITING

**Zip:** 510630

**Location 15:**

**City:** Guangzhou

**Country:** China

**Facility:** The Sixth Affiliated Hospital Sun Yat-sen University

**State:** Guangdong

**Status:** RECRUITING

**Zip:** 510655

**Location 16:**

**City:** Huizhou

**Country:** China

**Facility:** The Third Peoples Hospital of Huizhou City

**State:** Guangdong

**Status:** RECRUITING

**Zip:** 516002

**Location 17:**

**City:** Zhuhai

**Country:** China

**Facility:** Zhuhai Peoples Hospital

**State:** Guangdong

**Status:** RECRUITING

**Zip:** 519050

**Location 18:**

**City:** Yulin

**Country:** China

**Facility:** The First Peoples Hospital of Yulin

**State:** Guangxi

**Status:** RECRUITING

**Zip:** 537006

**Location 19:**

**City:** Yulin

**Country:** China

**Facility:** The Second Affiliated Hospital of Guilin Medical University

**State:** Guangxi

**Status:** RECRUITING

**Zip:** 541199

**Location 20:**

**City:** Guiyang

**Country:** China

**Facility:** The Affiliated Hospital of Guizhou Medical University

**State:** Guizhou

**Status:** RECRUITING

**Zip:** 550001

**Location 21:**

**City:** Cangzhou

**Country:** China

**Facility:** Cangzhou Central Hospital

**State:** Hebei

**Status:** RECRUITING

**Zip:** 061001

**Location 22:**

**City:** Tangshan

**Country:** China

**Facility:** Tangshan Gongren Hosipital

**State:** Hebei

**Status:** RECRUITING

**Zip:** 063000

**Location 23:**

**City:** Haerbin

**Country:** China

**Facility:** Heilongjiang Provincial Hospital

**State:** Heilongjiang

**Status:** RECRUITING

**Zip:** 150036

**Location 24:**

**City:** Kaifeng

**Country:** China

**Facility:** Huaihe Hospital of Henan University

**State:** Henan

**Status:** RECRUITING

**Zip:** 475000

**Location 25:**

**City:** Nanyang

**Country:** China

**Facility:** Nanyang Central Hospital

**State:** Henan

**Status:** RECRUITING

**Zip:** 473000

**Location 26:**

**City:** Zhengzhou

**Country:** China

**Facility:** The Seventh Peoples Hospital of Zhengzhou

**State:** Henan

**Status:** RECRUITING

**Zip:** 450016

**Location 27:**

**City:** Zhengzhou

**Country:** China

**Facility:** The First Affiliated hospital of Zhengzhou University

**State:** Henan

**Status:** RECRUITING

**Zip:** 450052

**Location 28:**

**City:** Wuhan

**Country:** China

**Facility:** The Central Hospital of Wuhan

**State:** Hubei

**Status:** RECRUITING

**Zip:** 430014

**Location 29:**

**City:** Wuhan

**Country:** China

**Facility:** Union Hospital Tongji Medical College Huazhong University of science and Technology

**State:** Hubei

**Status:** RECRUITING

**Zip:** 430022

**Location 30:**

**City:** Wuhan

**Country:** China

**Facility:** Wuhan No 1 Hospital

**State:** Hubei

**Status:** RECRUITING

**Zip:** 430022

**Location 31:**

**City:** Wuhan

**Country:** China

**Facility:** Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology

**State:** Hubei

**Status:** RECRUITING

**Zip:** 430030

**Location 32:**

**City:** Wuhan

**Country:** China

**Facility:** Wuhan Third Hospital-Tongren Hospital Of Wuhan University

**State:** Hubei

**Status:** RECRUITING

**Zip:** 430060

**Location 33:**

**City:** Changsha

**Country:** China

**Facility:** Hunan Provincial Peoples Hospital

**State:** Hunan

**Status:** RECRUITING

**Zip:** 410005

**Location 34:**

**City:** Changshu

**Country:** China

**Facility:** Changshu No1 Peoples Hospital

**State:** Jiangsu

**Status:** RECRUITING

**Zip:** 215500

**Location 35:**

**City:** Changshu

**Country:** China

**Facility:** Changshu NO2 Peoples Hospital

**State:** Jiangsu

**Status:** RECRUITING

**Zip:** 215523

**Location 36:**

**City:** Nantong

**Country:** China

**Facility:** Nantong First Peoples Hospital

**State:** Jiangsu

**Status:** RECRUITING

**Zip:** 226000

**Location 37:**

**City:** Suzhou

**Country:** China

**Facility:** The first peoples hospital of Kunshan

**State:** Jiangsu

**Status:** RECRUITING

**Zip:** 215300

**Location 38:**

**City:** Wuxi

**Country:** China

**Facility:** Wuxi Peoples Hospital

**State:** Jiangsu

**Status:** RECRUITING

**Zip:** 214023

**Location 39:**

**City:** Xuzhou

**Country:** China

**Facility:** The Affiliated Hospital of Xuzhou Medical University

**State:** Jiangsu

**Status:** RECRUITING

**Zip:** 221006

**Location 40:**

**City:** Nanchang

**Country:** China

**Facility:** Jiangxi Provincial People Hospital

**State:** Jiangxi

**Status:** RECRUITING

**Zip:** 330006

**Location 41:**

**City:** Nanchang

**Country:** China

**Facility:** The first affiliated Hospital of Nanchang University

**State:** Jiangxi

**Status:** RECRUITING

**Zip:** 330006

**Location 42:**

**City:** Nanchang

**Country:** China

**Facility:** The First Hospital of Nanchang

**State:** Jiangxi

**Status:** RECRUITING

**Zip:** 330008

**Location 43:**

**City:** Changchun

**Country:** China

**Facility:** The Second Hospital of Jilin University

**State:** Jilin

**Status:** RECRUITING

**Zip:** 13041

**Location 44:**

**City:** Dalian

**Country:** China

**Facility:** Dalian Municipal Central Hospital Affiliated Of Dalian Medical University

**State:** Liaoning

**Status:** RECRUITING

**Zip:** 116000

**Location 45:**

**City:** Dalian

**Country:** China

**Facility:** The First Affiliated Hospital of Dalian Medical University

**State:** Liaoning

**Status:** RECRUITING

**Zip:** 116000

**Location 46:**

**City:** Dalian

**Country:** China

**Facility:** The Second Hospital of Dalian Medical University

**State:** Liaoning

**Status:** RECRUITING

**Zip:** 116027

**Location 47:**

**City:** Jinzhou

**Country:** China

**Facility:** The First Affiliated Hospital of Jinzhou Medical University

**State:** Liaoning

**Status:** RECRUITING

**Zip:** 121000

**Location 48:**

**City:** Shenyang

**Country:** China

**Facility:** General Hospital of Northern Theater Command

**State:** Liaoning

**Status:** RECRUITING

**Zip:** 110016

**Location 49:**

**City:** Shenyang

**Country:** China

**Facility:** The Forth Affiliated Hospital of China Medical University

**State:** Liaoning

**Status:** RECRUITING

**Zip:** 110032

**Location 50:**

**City:** Xi'an

**Country:** China

**Facility:** Tangdu Hospital,Air Force Military Medical University

**State:** Shaanxi

**Status:** RECRUITING

**Zip:** 710038

**Location 51:**

**City:** Xi'an

**Country:** China

**Facility:** Shaanxi Provincial Peoples Hospital

**State:** Shaanxi

**Status:** RECRUITING

**Zip:** 710068

**Location 52:**

**City:** Jinan

**Country:** China

**Facility:** Qilu Hospital of Shandong University

**State:** Shandong

**Status:** RECRUITING

**Zip:** 250012

**Location 53:**

**City:** Jinan

**Country:** China

**Facility:** Jinan Central Hospital

**State:** Shandong

**Status:** RECRUITING

**Zip:** 250013

**Location 54:**

**City:** Jinan

**Country:** China

**Facility:** Shandong Qianfoshan Hospital

**State:** Shandong

**Status:** RECRUITING

**Zip:** 250014

**Location 55:**

**City:** Jinan

**Country:** China

**Facility:** Shandong Provincial Hospital

**State:** Shandong

**Status:** RECRUITING

**Zip:** 250021

**Location 56:**

**City:** Jining

**Country:** China

**Facility:** Affiliated hospital of Jining Medical University

**State:** Shandong

**Status:** RECRUITING

**Zip:** 272009

**Location 57:**

**City:** Zibo

**Country:** China

**Facility:** Zibo central Hospital

**State:** Shandong

**Status:** RECRUITING

**Zip:** 255030

**Location 58:**

**City:** Shanghai

**Country:** China

**Facility:** Xinhua Hospital Affiliated To Shanghai Jiaotong University School of Medicine

**State:** Shanghai

**Status:** RECRUITING

**Zip:** 200092

**Location 59:**

**City:** Taiyuan

**Country:** China

**Facility:** The Second Hospital of Shanxi Medical University

**State:** Shanxi

**Status:** RECRUITING

**Zip:** 030001

**Location 60:**

**City:** XI An

**Country:** China

**Facility:** The First Affiliated Hospital of Xi An Jiaotong University

**State:** Shanxi

**Status:** RECRUITING

**Zip:** 710061

**Location 61:**

**City:** Chengdu

**Country:** China

**Facility:** Chengdu First Peoples Hospital

**State:** Sichuan

**Status:** RECRUITING

**Zip:** 610041

**Location 62:**

**City:** Chengdu

**Country:** China

**Facility:** Chengdu Third Peoples Hospital

**State:** Sichuan

**Status:** RECRUITING

**Zip:** 61031

**Location 63:**

**City:** Tianjin

**Country:** China

**Facility:** Tianjin Peoples Hospital

**State:** Tianjin

**Status:** RECRUITING

**Zip:** 300120

**Location 64:**

**City:** Tianjin

**Country:** China

**Facility:** Tianjin Chest Hospital

**State:** Tianjin

**Status:** RECRUITING

**Zip:** 300222

**Location 65:**

**City:** Urumqi

**Country:** China

**Facility:** The First Affiliated Hospital of Xinjiang Medical University

**State:** Xinjiang

**Status:** RECRUITING

**Zip:** 830054

**Location 66:**

**City:** Kunming

**Country:** China

**Facility:** Yanan Hospital of Kunming City

**State:** Yunnan

**Status:** RECRUITING

**Zip:** 473009

**Location 67:**

**City:** Kunming

**Country:** China

**Facility:** First Affiliated Hospital of Kunming Medical University

**State:** Yunnan

**Status:** RECRUITING

**Zip:** 650032

**Location 68:**

**City:** Kunming

**Country:** China

**Facility:** Yunnan First Peoples Hospital

**State:** Yunnan

**Status:** RECRUITING

**Zip:** 650032

**Location 69:**

**City:** Hangzhou

**Country:** China

**Facility:** Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine

**State:** Zhejiang

**Status:** RECRUITING

**Zip:** 310016

**Location 70:**

**City:** Hangzhou

**Country:** China

**Facility:** the First Peoples Hospital of Xiaoshan District Hangzhou

**State:** Zhejiang

**Status:** RECRUITING

**Zip:** 311201

**Location 71:**

**City:** Huzhou

**Country:** China

**Facility:** Huzhou Central Hospital

**State:** Zhejiang

**Status:** RECRUITING

**Zip:** 310005

**Location 72:**

**City:** Huzhou

**Country:** China

**Facility:** The First Peoples Hospital of Huzhou

**State:** Zhejiang

**Status:** RECRUITING

**Zip:** 313000

**Location 73:**

**City:** Jiaxing

**Country:** China

**Facility:** Jiaxing Second Hospital

**State:** Zhejiang

**Status:** RECRUITING

**Zip:** 314000

**Location 74:**

**City:** Ningbo

**Country:** China

**Facility:** The first affiliated hospital of Ningbo university

**State:** Zhejiang

**Status:** RECRUITING

**Zip:** 315010

**Location 75:**

**City:** Ningbo

**Country:** China

**Facility:** Ningbo medical center lihuili hospital

**State:** Zhejiang

**Status:** RECRUITING

**Zip:** 315046

**Location 76:**

**City:** Shaoxing

**Country:** China

**Facility:** Shaoxing Second Hospital

**State:** Zhejiang

**Status:** RECRUITING

**Zip:** 312000

**Location 77:**

**City:** Beijing

**Country:** China

**Facility:** Beijing Anzhen Hospital, Capital Medical University

**Status:** RECRUITING

**Zip:** 100029

**Location 78:**

**City:** Shanghai

**Country:** China

**Facility:** Tongji Hospital of Tongji University

**Status:** RECRUITING

**Zip:** 200065

#### Overall Officials

**Official 1:**

**Affiliation:** Amgen

**Name:** MD

**Role:** STUDY_DIRECTOR

### IPD Sharing Statement Module

**Access Criteria:** Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen study/studies in scope, endpoints/outcomes of interest, statistical analysis plan, data requirements, publication plan, and qualifications of the researcher(s). In general, Amgen does not grant external requests for individual patient data for the purpose of re-evaluating safety and efficacy issues already addressed in the product labelling. Requests are reviewed by a committee of internal advisors. If not approved, a Data Sharing Independent Review Panel will arbitrate and make the final decision. Upon approval, information necessary to address the research question will be provided under the terms of a data sharing agreement. This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code where provided in analysis specifications. Further details are available at the URL below.

**Description:** De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request.

**Info Types:**

- STUDY_PROTOCOL

- SAP

- ICF

- CSR

**IPD Sharing:** YES

**Time Frame:** Data sharing requests relating to this study will be considered beginning 18 months after the study has ended and either 1) the product and indication have been granted marketing authorization in both the US and Europe or 2) clinical development for the product and/or indication discontinues and the data will not be submitted to regulatory authorities. There is no end date for eligibility to submit a data sharing request for this study.

**URL:** http://www.amgen.com/datasharing

### References Module

#### See Also Links

**Label:** AmgenTrials clinical trials website

**URL:** http://www.amgentrials.com

## Derived Section

### Condition Browse Module - Ancestors

- ID: D000001161

- Term: Arteriosclerosis

- ID: D000001157

- Term: Arterial Occlusive Diseases

- ID: D000014652

- Term: Vascular Diseases

### Condition Browse Module - Browse Branches

- Abbrev: BC10

- Name: Nervous System Diseases

- Abbrev: BC14

- Name: Heart and Blood Diseases

- Abbrev: All

- Name: All Conditions

- Abbrev: BC23

- Name: Symptoms and General Pathology

### Condition Browse Module - Browse Leaves

- ID: M22306

- Name: Stroke

- Relevance: LOW

- As Found: Unknown

- ID: M12155

- Name: Myocardial Infarction

- Relevance: LOW

- As Found: Unknown

- ID: M10282

- Name: Infarction

- Relevance: LOW

- As Found: Unknown

- ID: M26188

- Name: Atherosclerosis

- Relevance: HIGH

- As Found: Atherosclerotic Cardiovascular Disease

- ID: M4117

- Name: Angina Pectoris

- Relevance: LOW

- As Found: Unknown

- ID: M6845

- Name: Death

- Relevance: LOW

- As Found: Unknown

- ID: M4119

- Name: Angina, Unstable

- Relevance: LOW

- As Found: Unknown

- ID: M4469

- Name: Arteriosclerosis

- Relevance: LOW

- As Found: Unknown

- ID: M4465

- Name: Arterial Occlusive Diseases

- Relevance: LOW

- As Found: Unknown

- ID: M17400

- Name: Vascular Diseases

- Relevance: LOW

- As Found: Unknown

### Condition Browse Module - Meshes

- ID: D000002318

- Term: Cardiovascular Diseases

- ID: D000050197

- Term: Atherosclerosis

### Intervention Browse Module - Browse Branches

- Abbrev: Lipd

- Name: Lipid Regulating Agents

- Abbrev: All

- Name: All Drugs and Chemicals

### Intervention Browse Module - Browse Leaves

- ID: M348166

- Name: Evolocumab

- Relevance: LOW

- As Found: Unknown

### Misc Info Module

- Version Holder: 2024-05-24
